Investing Profile

Adam Wieschhaus

InvestorVC
Executive in Residence at General Inception
northpondventures.comSan Francisco, California
Photo of Adam Wieschhaus, General Inception

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
8
CompanyStageDateRound SizeTotal Raised
Slingshot Biosciences
Series AFeb 2023$26M
Series AJul 2021$23M
$49M
Co-investors: Corey Ritter (ARCH Venture Partners)
Vestaron
Series CAug 2022$10M
Series BFeb 2021$18M
$49M
Co-investors: Son Vo (Wilbur-Ellis [Cavallo]), Martin Alexander Gershon (Endeavor Venture Funds), Karl Kerksiek (Endeavor8)
Kytopen
Series ASep 2021$30M
$34M
Co-investors: Katie Rae (The Engine)
Torus Biosystems
Series AMay 2021$25M
$25M
Co-investors: David R. Walt
Isolere Bio
SeedMay 2021$7M
$7M
Ultivue
Series DApr 2021$50M
$97M
Co-investors: Keith Crandell (ARCH Venture Partners), Sharon Kedar (Northpond Ventures)
Executive in Residence General Inception2024 - Present
Managing Director Northpond Ventures2022 - 2023
Director Northpond Ventures2021 - 2022
Vice President Northpond Ventures2020 - 2021
Vice President, Healthcare Equity Research Cowen and Company2016 - 2020
Associate, Healthcare Equity Research Cowen and Company2014 - 2016
Postdoctoral Fellow Tufts Medical Center2013 - 2014